Eintrag weiter verarbeiten
Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial
Gespeichert in:
| Zeitschriftentitel: | Cell Transplantation |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Cell Transplantation, 22, 2013, 5, S. 767-777 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
SAGE Publications
|
| Schlagwörter: |
| author_facet |
Kaigler, Darnell Pagni, Giorgio Park, Chan Ho Braun, Thomas M. Holman, Lindsay A. Yi, Erica Tarle, Susan A. Bartel, Ronnda L. Giannobile, William V. Kaigler, Darnell Pagni, Giorgio Park, Chan Ho Braun, Thomas M. Holman, Lindsay A. Yi, Erica Tarle, Susan A. Bartel, Ronnda L. Giannobile, William V. |
|---|---|
| author |
Kaigler, Darnell Pagni, Giorgio Park, Chan Ho Braun, Thomas M. Holman, Lindsay A. Yi, Erica Tarle, Susan A. Bartel, Ronnda L. Giannobile, William V. |
| spellingShingle |
Kaigler, Darnell Pagni, Giorgio Park, Chan Ho Braun, Thomas M. Holman, Lindsay A. Yi, Erica Tarle, Susan A. Bartel, Ronnda L. Giannobile, William V. Cell Transplantation Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial Transplantation Cell Biology Biomedical Engineering |
| author_sort |
kaigler, darnell |
| spelling |
Kaigler, Darnell Pagni, Giorgio Park, Chan Ho Braun, Thomas M. Holman, Lindsay A. Yi, Erica Tarle, Susan A. Bartel, Ronnda L. Giannobile, William V. 0963-6897 1555-3892 SAGE Publications Transplantation Cell Biology Biomedical Engineering http://dx.doi.org/10.3727/096368912x652968 <jats:p>Stem cell therapy offers potential in the regeneration of craniofacial bone defects; however, it has not been studied clinically. Tissue repair cells (TRCs) isolated from bone marrow represent a mixed stem and progenitor population enriched in CD90- and CD14-positive cells. In this phase I/II, randomized, controlled feasibility trial, we investigated TRC cell therapy to reconstruct localized craniofacial bone defects. Twenty-four patients requiring localized reconstruction of jawbone defects participated in this longitudinal trial. For regenerative therapy, patients were randomized to receive either guided bone regeneration (GBR) or TRC transplantation. At 6 or 12 weeks following treatment, clinical and radiographic assessments of bone repair were performed. Bone biopsies were harvested and underwent quantitative micro-computed tomographic (μCT) and bone histomorphometric analyses. Oral implants were installed, subsequently restored, and functionally loaded with tooth restorations. Reconstructed sites were assessed for 1 year following therapy. No study-related, serious adverse events were reported. Following therapy, clinical, radiographic, tomographic, and histological measures demonstrated that TRC therapy accelerated alveolar bone regeneration compared to GBR therapy. Additionally, TRC treatment significantly reduced the need for secondary bone grafting at the time of oral implant placement with a fivefold decrease in implant bony dehiscence exposure (residual bone defects) as compared to GBR-treated sites ( p < 0.01). Transplantation of TRCs for treatment of alveolar bone defects appears safe and accelerates bone regeneration, enabling jawbone reconstruction with oral implants. The results from this trial support expanded studies of TRC therapy in the treatment of craniofacial deformities ( ClinicalTrials.gov number CT00755911).</jats:p> Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial Cell Transplantation |
| doi_str_mv |
10.3727/096368912x652968 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Biologie Technik |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzcyNy8wOTYzNjg5MTJ4NjUyOTY4 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzcyNy8wOTYzNjg5MTJ4NjUyOTY4 |
| institution |
DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 |
| imprint |
SAGE Publications, 2013 |
| imprint_str_mv |
SAGE Publications, 2013 |
| issn |
0963-6897 1555-3892 |
| issn_str_mv |
0963-6897 1555-3892 |
| language |
English |
| mega_collection |
SAGE Publications (CrossRef) |
| match_str |
kaigler2013stemcelltherapyforcraniofacialboneregenerationarandomizedcontrolledfeasibilitytrial |
| publishDateSort |
2013 |
| publisher |
SAGE Publications |
| recordtype |
ai |
| record_format |
ai |
| series |
Cell Transplantation |
| source_id |
49 |
| title |
Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_unstemmed |
Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_full |
Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_fullStr |
Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_full_unstemmed |
Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_short |
Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_sort |
stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial |
| topic |
Transplantation Cell Biology Biomedical Engineering |
| url |
http://dx.doi.org/10.3727/096368912x652968 |
| publishDate |
2013 |
| physical |
767-777 |
| description |
<jats:p>Stem cell therapy offers potential in the regeneration of craniofacial bone defects; however, it has not been studied clinically. Tissue repair cells (TRCs) isolated from bone marrow represent a mixed stem and progenitor population enriched in CD90- and CD14-positive cells. In this phase I/II, randomized, controlled feasibility trial, we investigated TRC cell therapy to reconstruct localized craniofacial bone defects. Twenty-four patients requiring localized reconstruction of jawbone defects participated in this longitudinal trial. For regenerative therapy, patients were randomized to receive either guided bone regeneration (GBR) or TRC transplantation. At 6 or 12 weeks following treatment, clinical and radiographic assessments of bone repair were performed. Bone biopsies were harvested and underwent quantitative micro-computed tomographic (μCT) and bone histomorphometric analyses. Oral implants were installed, subsequently restored, and functionally loaded with tooth restorations. Reconstructed sites were assessed for 1 year following therapy. No study-related, serious adverse events were reported. Following therapy, clinical, radiographic, tomographic, and histological measures demonstrated that TRC therapy accelerated alveolar bone regeneration compared to GBR therapy. Additionally, TRC treatment significantly reduced the need for secondary bone grafting at the time of oral implant placement with a fivefold decrease in implant bony dehiscence exposure (residual bone defects) as compared to GBR-treated sites ( p < 0.01). Transplantation of TRCs for treatment of alveolar bone defects appears safe and accelerates bone regeneration, enabling jawbone reconstruction with oral implants. The results from this trial support expanded studies of TRC therapy in the treatment of craniofacial deformities ( ClinicalTrials.gov number CT00755911).</jats:p> |
| container_issue |
5 |
| container_start_page |
767 |
| container_title |
Cell Transplantation |
| container_volume |
22 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792346722735751179 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:43:07.73Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Stem+Cell+Therapy+for+Craniofacial+Bone+Regeneration%3A+A+Randomized%2C+Controlled+Feasibility+Trial&rft.date=2013-05-01&genre=article&issn=1555-3892&volume=22&issue=5&spage=767&epage=777&pages=767-777&jtitle=Cell+Transplantation&atitle=Stem+Cell+Therapy+for+Craniofacial+Bone+Regeneration%3A+A+Randomized%2C+Controlled+Feasibility+Trial&aulast=Giannobile&aufirst=William+V.&rft_id=info%3Adoi%2F10.3727%2F096368912x652968&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792346722735751179 |
| author | Kaigler, Darnell, Pagni, Giorgio, Park, Chan Ho, Braun, Thomas M., Holman, Lindsay A., Yi, Erica, Tarle, Susan A., Bartel, Ronnda L., Giannobile, William V. |
| author_facet | Kaigler, Darnell, Pagni, Giorgio, Park, Chan Ho, Braun, Thomas M., Holman, Lindsay A., Yi, Erica, Tarle, Susan A., Bartel, Ronnda L., Giannobile, William V., Kaigler, Darnell, Pagni, Giorgio, Park, Chan Ho, Braun, Thomas M., Holman, Lindsay A., Yi, Erica, Tarle, Susan A., Bartel, Ronnda L., Giannobile, William V. |
| author_sort | kaigler, darnell |
| container_issue | 5 |
| container_start_page | 767 |
| container_title | Cell Transplantation |
| container_volume | 22 |
| description | <jats:p>Stem cell therapy offers potential in the regeneration of craniofacial bone defects; however, it has not been studied clinically. Tissue repair cells (TRCs) isolated from bone marrow represent a mixed stem and progenitor population enriched in CD90- and CD14-positive cells. In this phase I/II, randomized, controlled feasibility trial, we investigated TRC cell therapy to reconstruct localized craniofacial bone defects. Twenty-four patients requiring localized reconstruction of jawbone defects participated in this longitudinal trial. For regenerative therapy, patients were randomized to receive either guided bone regeneration (GBR) or TRC transplantation. At 6 or 12 weeks following treatment, clinical and radiographic assessments of bone repair were performed. Bone biopsies were harvested and underwent quantitative micro-computed tomographic (μCT) and bone histomorphometric analyses. Oral implants were installed, subsequently restored, and functionally loaded with tooth restorations. Reconstructed sites were assessed for 1 year following therapy. No study-related, serious adverse events were reported. Following therapy, clinical, radiographic, tomographic, and histological measures demonstrated that TRC therapy accelerated alveolar bone regeneration compared to GBR therapy. Additionally, TRC treatment significantly reduced the need for secondary bone grafting at the time of oral implant placement with a fivefold decrease in implant bony dehiscence exposure (residual bone defects) as compared to GBR-treated sites ( p < 0.01). Transplantation of TRCs for treatment of alveolar bone defects appears safe and accelerates bone regeneration, enabling jawbone reconstruction with oral implants. The results from this trial support expanded studies of TRC therapy in the treatment of craniofacial deformities ( ClinicalTrials.gov number CT00755911).</jats:p> |
| doi_str_mv | 10.3727/096368912x652968 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Biologie, Technik |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzcyNy8wOTYzNjg5MTJ4NjUyOTY4 |
| imprint | SAGE Publications, 2013 |
| imprint_str_mv | SAGE Publications, 2013 |
| institution | DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4 |
| issn | 0963-6897, 1555-3892 |
| issn_str_mv | 0963-6897, 1555-3892 |
| language | English |
| last_indexed | 2024-03-01T17:43:07.73Z |
| match_str | kaigler2013stemcelltherapyforcraniofacialboneregenerationarandomizedcontrolledfeasibilitytrial |
| mega_collection | SAGE Publications (CrossRef) |
| physical | 767-777 |
| publishDate | 2013 |
| publishDateSort | 2013 |
| publisher | SAGE Publications |
| record_format | ai |
| recordtype | ai |
| series | Cell Transplantation |
| source_id | 49 |
| spelling | Kaigler, Darnell Pagni, Giorgio Park, Chan Ho Braun, Thomas M. Holman, Lindsay A. Yi, Erica Tarle, Susan A. Bartel, Ronnda L. Giannobile, William V. 0963-6897 1555-3892 SAGE Publications Transplantation Cell Biology Biomedical Engineering http://dx.doi.org/10.3727/096368912x652968 <jats:p>Stem cell therapy offers potential in the regeneration of craniofacial bone defects; however, it has not been studied clinically. Tissue repair cells (TRCs) isolated from bone marrow represent a mixed stem and progenitor population enriched in CD90- and CD14-positive cells. In this phase I/II, randomized, controlled feasibility trial, we investigated TRC cell therapy to reconstruct localized craniofacial bone defects. Twenty-four patients requiring localized reconstruction of jawbone defects participated in this longitudinal trial. For regenerative therapy, patients were randomized to receive either guided bone regeneration (GBR) or TRC transplantation. At 6 or 12 weeks following treatment, clinical and radiographic assessments of bone repair were performed. Bone biopsies were harvested and underwent quantitative micro-computed tomographic (μCT) and bone histomorphometric analyses. Oral implants were installed, subsequently restored, and functionally loaded with tooth restorations. Reconstructed sites were assessed for 1 year following therapy. No study-related, serious adverse events were reported. Following therapy, clinical, radiographic, tomographic, and histological measures demonstrated that TRC therapy accelerated alveolar bone regeneration compared to GBR therapy. Additionally, TRC treatment significantly reduced the need for secondary bone grafting at the time of oral implant placement with a fivefold decrease in implant bony dehiscence exposure (residual bone defects) as compared to GBR-treated sites ( p < 0.01). Transplantation of TRCs for treatment of alveolar bone defects appears safe and accelerates bone regeneration, enabling jawbone reconstruction with oral implants. The results from this trial support expanded studies of TRC therapy in the treatment of craniofacial deformities ( ClinicalTrials.gov number CT00755911).</jats:p> Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial Cell Transplantation |
| spellingShingle | Kaigler, Darnell, Pagni, Giorgio, Park, Chan Ho, Braun, Thomas M., Holman, Lindsay A., Yi, Erica, Tarle, Susan A., Bartel, Ronnda L., Giannobile, William V., Cell Transplantation, Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial, Transplantation, Cell Biology, Biomedical Engineering |
| title | Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_full | Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_fullStr | Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_full_unstemmed | Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_short | Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| title_sort | stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial |
| title_unstemmed | Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial |
| topic | Transplantation, Cell Biology, Biomedical Engineering |
| url | http://dx.doi.org/10.3727/096368912x652968 |